Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

作者：Jae Yoon Jeon, Qiuhong Zhao, Daelynn R. Buelow, Mitch A. Phelps, Alison R. Walker, Alice S. Mims, Sumithira Vasu, Gregory K. Behbehani, James S. Blachly, William Blum, Rebecca B. Klisovic, John C. Byrd, Ramiro Garzon, Sharyn D. Baker, Bhavana Bhatnagar · 发表于：Investigational New Drugs · 年份：2019 · DOI：10.1007/s10637-019-00786-4 · 被引用次数：43 · 研究领域：Acute Myeloid Leukemia Research、Myeloproliferative Neoplasms: Diagnosis and Treatment、Chronic Lymphocytic Leukemia Research